105 related articles for article (PubMed ID: 27909217)
1. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.
Rao DS; O'Connell RM; Chaudhuri AA; Garcia-Flores Y; Geiger TL; Baltimore D
Immunity; 2010 Jul; 33(1):48-59. PubMed ID: 20598588
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function.
Shi C; Sakuma M; Mooroka T; Liscoe A; Gao H; Croce KJ; Sharma A; Kaplan D; Greaves DR; Wang Y; Simon DI
Blood; 2008 Dec; 112(12):4699-711. PubMed ID: 18799727
[TBL] [Abstract][Full Text] [Related]
4. FoxP1 stimulates angiogenesis by repressing the inhibitory guidance protein semaphorin 5B in endothelial cells.
Grundmann S; Lindmayer C; Hans FP; Hoefer I; Helbing T; Pasterkamp G; Bode C; de Kleijn D; Moser M
PLoS One; 2013; 8(9):e70873. PubMed ID: 24023716
[TBL] [Abstract][Full Text] [Related]
5. Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1.
Shi C; Zhang X; Chen Z; Sulaiman K; Feinberg MW; Ballantyne CM; Jain MK; Simon DI
J Clin Invest; 2004 Aug; 114(3):408-18. PubMed ID: 15286807
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model.
Felce SL; Anderson AP; Maguire S; Gascoyne DM; Armstrong RN; Wong KK; Li D; Banham AH
Front Oncol; 2020; 10():448. PubMed ID: 32309216
[TBL] [Abstract][Full Text] [Related]
7. Foxp1 Is Required for Renal Intercalated Cell Differentiation and Acid-Base Regulation.
Wu ST; Feng Y; Song R; Qi Y; Li L; Lu D; Wang Y; Wu W; Morgan A; Wang X; Xia Y; Liu R; Alexander SI; Wong J; Zhang Y; Zheng X
J Am Soc Nephrol; 2024 May; 35(5):533-548. PubMed ID: 38332484
[No Abstract] [Full Text] [Related]
8. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.
Li J; Chin CR; Ying HY; Meydan C; Teater MR; Xia M; Farinha P; Takata K; Chu CS; Jiang Y; Eagles J; Passerini V; Tang Z; Rivas MA; Weigert O; Pugh TJ; Chadburn A; Steidl C; Scott DW; Roeder RG; Mason CE; Zappasodi R; Béguelin W; Melnick AM
Nat Commun; 2024 Apr; 15(1):2879. PubMed ID: 38570506
[TBL] [Abstract][Full Text] [Related]
9. Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis.
Martínez MR; Corradin A; Klein U; Álvarez MJ; Toffolo GM; di Camillo B; Califano A; Stolovitzky GA
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2672-7. PubMed ID: 22308355
[TBL] [Abstract][Full Text] [Related]
10. An endogenous retrovirus regulates tumor-specific expression of the immune transcriptional regulator SP140.
Dziulko AK; Allen H; Chuong EB
Hum Mol Genet; 2024 May; ():. PubMed ID: 38751339
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.
Sandlund JT; Martin MG
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):589-597. PubMed ID: 27913533
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins.
van Andel H; Ren Z; Koopmans I; Joosten SP; Kocemba KA; de Lau W; Kersten MJ; de Bruin AM; Guikema JE; Clevers H; Spaargaren M; Pals ST
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):376-381. PubMed ID: 28028233
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
Ma ES
Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Predictive Biomarkers in Diffuse Large B-cell Lymphoma.
Chan A; Dogan A
Surg Pathol Clin; 2019 Sep; 12(3):699-707. PubMed ID: 31352982
[No Abstract] [Full Text] [Related]
15. miR-34a-FOXP1 Loop in Ovarian Cancer.
Dirimtekin E; Mortoglou M; Alavanda C; Benomar Yemlahi A; Arslan Ates E; Guney I; Uysal-Onganer P
ACS Omega; 2023 Aug; 8(30):27743-27750. PubMed ID: 37546627
[TBL] [Abstract][Full Text] [Related]
16. Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases.
Hu YZ; Li Q; Wang PF; Li XP; Hu ZL
Front Oncol; 2023; 13():1140813. PubMed ID: 37182123
[TBL] [Abstract][Full Text] [Related]
17. Identification of a forkhead box protein transcriptional network induced in human neutrophils in response to inflammatory stimuli.
Ismailova A; Salehi-Tabar R; Dimitrov V; Memari B; Barbier C; White JH
Front Immunol; 2023; 14():1123344. PubMed ID: 36756115
[TBL] [Abstract][Full Text] [Related]
18. Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion.
Kaminskiy Y; Kuznetsova V; Kudriaeva A; Zmievskaya E; Bulatov E
Front Immunol; 2022; 13():971045. PubMed ID: 36268015
[TBL] [Abstract][Full Text] [Related]
19. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.
Li H; Han X; Yang S; Wang Y; Dong Y; Tang T
Oncogene; 2021 Apr; 40(15):2785-2802. PubMed ID: 33716296
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Alternative Splicing in Tumor-immune Cell Interactions.
Wang Y; Zhang H; Jiao B; Nie J; Li X; Wang W; Wang H
Curr Cancer Drug Targets; 2020; 20(10):729-740. PubMed ID: 32560607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
